QX-001352
/ QuantX Biosciences
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 26, 2025
QX-001352 is a novel and specific inhibitor of PARG with potentially BIC in vitro and in vivo anti-tumor efficacy
(AACR 2025)
- "QX-001352 possesses highly desirable physicochemical properties and demonstrated favorable off-target profiles. Thus QX-001352 may be an effective PARG inhibitor in the clinic."
Preclinical • Gastric Cancer • Oncology • Ovarian Cancer • Solid Tumor • PARP1
1 to 1
Of
1
Go to page
1